408 related articles for article (PubMed ID: 24759153)
1. Minocycline prevents osmotic demyelination associated with aquaresis.
Takagi H; Sugimura Y; Suzuki H; Iwama S; Izumida H; Fujisawa H; Ogawa K; Nakashima K; Ochiai H; Takeuchi S; Kiyota A; Suga H; Goto M; Banno R; Arima H; Oiso Y
Kidney Int; 2014 Nov; 86(5):954-64. PubMed ID: 24759153
[TBL] [Abstract][Full Text] [Related]
2. Myoinositol administration improves survival and reduces myelinolysis after rapid correction of chronic hyponatremia in rats.
Silver SM; Schroeder BM; Sterns RH; Rojiani AM
J Neuropathol Exp Neurol; 2006 Jan; 65(1):37-44. PubMed ID: 16410747
[TBL] [Abstract][Full Text] [Related]
3. Minocycline prevents osmotic demyelination syndrome by inhibiting the activation of microglia.
Suzuki H; Sugimura Y; Iwama S; Suzuki H; Nobuaki O; Nagasaki H; Arima H; Sawada M; Oiso Y
J Am Soc Nephrol; 2010 Dec; 21(12):2090-8. PubMed ID: 21030598
[TBL] [Abstract][Full Text] [Related]
4. Urea minimizes brain complications following rapid correction of chronic hyponatremia compared with vasopressin antagonist or hypertonic saline.
Gankam Kengne F; Couturier BS; Soupart A; Decaux G
Kidney Int; 2015 Feb; 87(2):323-31. PubMed ID: 25100046
[TBL] [Abstract][Full Text] [Related]
5. Protective effect of dexamethasone on osmotic-induced demyelination in rats.
Sugimura Y; Murase T; Takefuji S; Hayasaka S; Takagishi Y; Oiso Y; Murata Y
Exp Neurol; 2005 Mar; 192(1):178-83. PubMed ID: 15698632
[TBL] [Abstract][Full Text] [Related]
6. Minocycline protects against neurologic complications of rapid correction of hyponatremia.
Gankam-Kengne F; Soupart A; Pochet R; Brion JP; Decaux G
J Am Soc Nephrol; 2010 Dec; 21(12):2099-108. PubMed ID: 21051736
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic effects of tolvaptan, a potent, selective nonpeptide vasopressin V2 receptor antagonist, in rats with acute and chronic severe hyponatremia.
Miyazaki T; Yamamura Y; Onogawa T; Nakamura S; Kinoshita S; Nakayama S; Fujiki H; Mori T
Endocrinology; 2005 Jul; 146(7):3037-43. PubMed ID: 15831573
[TBL] [Abstract][Full Text] [Related]
8. Time-dependent changes in proinflammatory and neurotrophic responses of microglia and astrocytes in a rat model of osmotic demyelination syndrome.
Iwama S; Sugimura Y; Suzuki H; Suzuki H; Murase T; Ozaki N; Nagasaki H; Arima H; Murata Y; Sawada M; Oiso Y
Glia; 2011 Mar; 59(3):452-62. PubMed ID: 21264951
[TBL] [Abstract][Full Text] [Related]
9. Azotemia protects the brain from osmotic demyelination on rapid correction of hyponatremia.
Dhrolia MF; Akhtar SF; Ahmed E; Naqvi A; Rizvi A
Saudi J Kidney Dis Transpl; 2014 May; 25(3):558-66. PubMed ID: 24821152
[TBL] [Abstract][Full Text] [Related]
10. Role of microglia in the pathogenesis of osmotic-induced demyelination.
Takefuji S; Murase T; Sugimura Y; Takagishi Y; Hayasaka S; Oiso Y; Murata Y
Exp Neurol; 2007 Mar; 204(1):88-94. PubMed ID: 17126835
[TBL] [Abstract][Full Text] [Related]
11. Hypertonic saline and desmopressin: a simple strategy for safe correction of severe hyponatremia.
Sood L; Sterns RH; Hix JK; Silver SM; Chen L
Am J Kidney Dis; 2013 Apr; 61(4):571-8. PubMed ID: 23266328
[TBL] [Abstract][Full Text] [Related]
12. Treating profound hyponatremia: a strategy for controlled correction.
Sterns RH; Hix JK; Silver S
Am J Kidney Dis; 2010 Oct; 56(4):774-9. PubMed ID: 20709440
[TBL] [Abstract][Full Text] [Related]
13. Blood-brain barrier disruption and complement activation in the brain following rapid correction of chronic hyponatremia.
Baker EA; Tian Y; Adler S; Verbalis JG
Exp Neurol; 2000 Oct; 165(2):221-30. PubMed ID: 10993682
[TBL] [Abstract][Full Text] [Related]
14. [Etiology, diagnostics and therapy of hyponatremias].
Laczi F
Orv Hetil; 2008 Jul; 149(29):1347-54. PubMed ID: 18617466
[TBL] [Abstract][Full Text] [Related]
15. Astrocytes are an early target in osmotic demyelination syndrome.
Gankam Kengne F; Nicaise C; Soupart A; Boom A; Schiettecatte J; Pochet R; Brion JP; Decaux G
J Am Soc Nephrol; 2011 Oct; 22(10):1834-45. PubMed ID: 21885671
[TBL] [Abstract][Full Text] [Related]
16. Reinduction of hyponatremia improves survival in rats with myelinolysis-related neurologic symptoms.
Soupart A; Penninckx R; Stenuit A; Perier O; Decaux G
J Neuropathol Exp Neurol; 1996 May; 55(5):594-601. PubMed ID: 8627349
[TBL] [Abstract][Full Text] [Related]
17. Management of severe hyponatremia: infusion of hypertonic saline and desmopressin or infusion of vasopressin inhibitors?
Tzamaloukas AH; Shapiro JI; Raj DS; Murata GH; Glew RH; Malhotra D
Am J Med Sci; 2014 Nov; 348(5):432-9. PubMed ID: 25247759
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic challenges in the management of osmotic demyelination syndrome: A case report of a favorable outcome from a tertiary center.
Elshafei M; Danjuma MI; Tahir RE
Medicine (Baltimore); 2020 Jun; 99(24):e20283. PubMed ID: 32541452
[TBL] [Abstract][Full Text] [Related]
19. Hypertonic Saline for Hyponatremia: Meeting Goals and Avoiding Harm.
Rondon-Berrios H; Sterns RH
Am J Kidney Dis; 2022 Jun; 79(6):890-896. PubMed ID: 34508830
[TBL] [Abstract][Full Text] [Related]
20. [Hyponatremia in heart failure: physiopathology and pharmacological approach].
Robledo GG; Cantillo DS; Comín Colet J
Endocrinol Nutr; 2010 May; 57 Suppl 2():10-4. PubMed ID: 21130957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
